CN115825316A - 基于超临界色谱法的药物有效成分分析方法及装置 - Google Patents
基于超临界色谱法的药物有效成分分析方法及装置 Download PDFInfo
- Publication number
- CN115825316A CN115825316A CN202310116245.XA CN202310116245A CN115825316A CN 115825316 A CN115825316 A CN 115825316A CN 202310116245 A CN202310116245 A CN 202310116245A CN 115825316 A CN115825316 A CN 115825316A
- Authority
- CN
- China
- Prior art keywords
- data
- target
- primary
- extraction
- standard
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 174
- 238000000034 method Methods 0.000 title claims abstract description 31
- 239000004480 active ingredient Substances 0.000 title claims abstract description 30
- 238000004808 supercritical fluid chromatography Methods 0.000 title claims abstract description 19
- 238000000605 extraction Methods 0.000 claims abstract description 124
- 229940079593 drug Drugs 0.000 claims abstract description 105
- 238000000926 separation method Methods 0.000 claims description 87
- 238000001914 filtration Methods 0.000 claims description 28
- 239000004615 ingredient Substances 0.000 claims description 26
- 238000004140 cleaning Methods 0.000 claims description 9
- 230000002159 abnormal effect Effects 0.000 claims description 8
- 238000009499 grossing Methods 0.000 claims description 7
- 238000005406 washing Methods 0.000 claims 1
- 239000000306 component Substances 0.000 description 130
- 238000004458 analytical method Methods 0.000 description 13
- 238000010992 reflux Methods 0.000 description 9
- 230000006870 function Effects 0.000 description 8
- 238000010438 heat treatment Methods 0.000 description 8
- 241000202807 Glycyrrhiza Species 0.000 description 7
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 7
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 7
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 7
- 229940010454 licorice Drugs 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 5
- 239000003607 modifier Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 4
- 235000019410 glycyrrhizin Nutrition 0.000 description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 3
- 241000213006 Angelica dahurica Species 0.000 description 3
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 3
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 3
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000013473 artificial intelligence Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- CJIJXIFQYOPWTF-UHFFFAOYSA-N 7-hydroxycoumarin Natural products O1C(=O)C=CC2=CC(O)=CC=C21 CJIJXIFQYOPWTF-UHFFFAOYSA-N 0.000 description 1
- -1 7-methyl coumarine Chemical compound 0.000 description 1
- 240000001879 Digitalis lutea Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-USTPAGJBSA-N Neoisoliquiritigenin Natural products O=C(/C=C/c1ccc(O)cc1)c1c(O)cc(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O2)cc1 XQWFHGOIUZFQPJ-USTPAGJBSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-LXGDFETPSA-N Neoisoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1O)=CC=C1C(=O)\C=C\C1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-LXGDFETPSA-N 0.000 description 1
- XQWFHGOIUZFQPJ-UHFFFAOYSA-N Neoisoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1O)=CC=C1C(=O)C=CC1=CC=C(O)C=C1 XQWFHGOIUZFQPJ-UHFFFAOYSA-N 0.000 description 1
- HJBUYKZTEBZNSH-ZRWXNEIDSA-N Neoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C(=O)C[C@H](O2)C=3C=CC(O)=CC=3)C2=C1 HJBUYKZTEBZNSH-ZRWXNEIDSA-N 0.000 description 1
- HJBUYKZTEBZNSH-ONJCETCRSA-N Neoliquiritin Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C(=O)C[C@@H](O2)C=3C=CC(O)=CC=3)C2=C1 HJBUYKZTEBZNSH-ONJCETCRSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 238000010812 external standard method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000010262 high-speed countercurrent chromatography Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000010813 internal standard method Methods 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000005426 pharmaceutical component Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- ORHBXUUXSCNDEV-UHFFFAOYSA-N umbelliferone Chemical compound C1=CC(=O)OC2=CC(O)=CC=C21 ORHBXUUXSCNDEV-UHFFFAOYSA-N 0.000 description 1
- HFTAFOQKODTIJY-UHFFFAOYSA-N umbelliferone Natural products Cc1cc2C=CC(=O)Oc2cc1OCC=CC(C)(C)O HFTAFOQKODTIJY-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/54—Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310116245.XA CN115825316B (zh) | 2023-02-15 | 2023-02-15 | 基于超临界色谱法的药物有效成分分析方法及装置 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310116245.XA CN115825316B (zh) | 2023-02-15 | 2023-02-15 | 基于超临界色谱法的药物有效成分分析方法及装置 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115825316A true CN115825316A (zh) | 2023-03-21 |
CN115825316B CN115825316B (zh) | 2023-06-16 |
Family
ID=85521430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310116245.XA Active CN115825316B (zh) | 2023-02-15 | 2023-02-15 | 基于超临界色谱法的药物有效成分分析方法及装置 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115825316B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118173190A (zh) * | 2024-05-14 | 2024-06-11 | 达州市农业科学研究院(达州市苎麻科学研究所、达州市薯类作物研究所) | 基于大数据的百部药材中有效成份分析系统及方法 |
Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068828A1 (en) * | 2000-12-08 | 2003-04-10 | Dadala Vijaya Kumar | Novel method for chromatographic finger printing and standardization of single medicines and formulations |
JP2007034598A (ja) * | 2005-07-26 | 2007-02-08 | Mitsubishi Electric Corp | 情報調査装置、情報調査方法、記録媒体 |
US20070142720A1 (en) * | 2004-05-24 | 2007-06-21 | Trent Ridder | Apparatus and methods for mitigating the effects of foreign interferents on analyte measurements in spectroscopy |
JP2007310454A (ja) * | 2006-05-16 | 2007-11-29 | Nippon Hoso Kyokai <Nhk> | 画像評価装置および被験者集中度算出装置、並びに、画像評価プログラムおよび被験者集中度算出プログラム |
US20090179147A1 (en) * | 2008-01-16 | 2009-07-16 | Milgram K Eric | Systems, methods, and computer-readable medium for determining composition of chemical constituents in a complex mixture |
US20110196620A1 (en) * | 2008-08-06 | 2011-08-11 | Johannes Lampe | Opportunity sector analysis tool |
CN104977379A (zh) * | 2014-04-14 | 2015-10-14 | 上海医药工业研究院 | 广东紫珠多组分同时测定方法及指纹图谱构建方法和应用 |
US20160131329A1 (en) * | 2014-11-07 | 2016-05-12 | Lg Innotek Co., Ltd. | Light Emitting Module, Backlight Unit Including the Module, and Display Apparatus Including the Unit |
CN107449849A (zh) * | 2017-10-11 | 2017-12-08 | 天津中医药大学 | 一种中药鉴别方法 |
CN109271515A (zh) * | 2018-09-19 | 2019-01-25 | 南京邮电大学 | 一种基于聚类分析的抗生素药物风险分级方法 |
CN110295181A (zh) * | 2019-06-18 | 2019-10-01 | 山东大学 | 一种利用生物发光报告系统鉴定抗生素种类的方法 |
CN112381155A (zh) * | 2020-11-17 | 2021-02-19 | 上海交通大学 | 基于人工智能的有机物样本处理方法、装置、设备及存储介质 |
WO2021093354A1 (zh) * | 2019-11-11 | 2021-05-20 | 中国药科大学 | 一种基于人工智能的中药识别方法 |
WO2021174946A1 (zh) * | 2020-10-12 | 2021-09-10 | 平安科技(深圳)有限公司 | 可视化方法、系统、计算机设备和存储介质 |
JP2021162312A (ja) * | 2020-03-30 | 2021-10-11 | 東ソー株式会社 | クロマトグラフの運転状態の推定方法 |
CN113694128A (zh) * | 2021-07-27 | 2021-11-26 | 吉林化工学院 | 一种响应面法优化乌拉草中含有士的宁的生物碱的提取工艺 |
CN114112980A (zh) * | 2022-01-24 | 2022-03-01 | 武汉宏韧生物医药股份有限公司 | 一种基于数据分析的药物组分检测方法与系统 |
WO2023000653A1 (zh) * | 2021-07-19 | 2023-01-26 | 湖南大学 | 一种图卷积神经网络高光谱医药成分分析的实现方法 |
-
2023
- 2023-02-15 CN CN202310116245.XA patent/CN115825316B/zh active Active
Patent Citations (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030068828A1 (en) * | 2000-12-08 | 2003-04-10 | Dadala Vijaya Kumar | Novel method for chromatographic finger printing and standardization of single medicines and formulations |
US20070142720A1 (en) * | 2004-05-24 | 2007-06-21 | Trent Ridder | Apparatus and methods for mitigating the effects of foreign interferents on analyte measurements in spectroscopy |
JP2007034598A (ja) * | 2005-07-26 | 2007-02-08 | Mitsubishi Electric Corp | 情報調査装置、情報調査方法、記録媒体 |
JP2007310454A (ja) * | 2006-05-16 | 2007-11-29 | Nippon Hoso Kyokai <Nhk> | 画像評価装置および被験者集中度算出装置、並びに、画像評価プログラムおよび被験者集中度算出プログラム |
US20090179147A1 (en) * | 2008-01-16 | 2009-07-16 | Milgram K Eric | Systems, methods, and computer-readable medium for determining composition of chemical constituents in a complex mixture |
US20110196620A1 (en) * | 2008-08-06 | 2011-08-11 | Johannes Lampe | Opportunity sector analysis tool |
CN104977379A (zh) * | 2014-04-14 | 2015-10-14 | 上海医药工业研究院 | 广东紫珠多组分同时测定方法及指纹图谱构建方法和应用 |
CN105588010A (zh) * | 2014-11-07 | 2016-05-18 | Lg伊诺特有限公司 | 发光模块、包括模块的背光单元及包括该单元的显示装置 |
US20160131329A1 (en) * | 2014-11-07 | 2016-05-12 | Lg Innotek Co., Ltd. | Light Emitting Module, Backlight Unit Including the Module, and Display Apparatus Including the Unit |
CN107449849A (zh) * | 2017-10-11 | 2017-12-08 | 天津中医药大学 | 一种中药鉴别方法 |
CN109271515A (zh) * | 2018-09-19 | 2019-01-25 | 南京邮电大学 | 一种基于聚类分析的抗生素药物风险分级方法 |
CN110295181A (zh) * | 2019-06-18 | 2019-10-01 | 山东大学 | 一种利用生物发光报告系统鉴定抗生素种类的方法 |
WO2021093354A1 (zh) * | 2019-11-11 | 2021-05-20 | 中国药科大学 | 一种基于人工智能的中药识别方法 |
JP2021162312A (ja) * | 2020-03-30 | 2021-10-11 | 東ソー株式会社 | クロマトグラフの運転状態の推定方法 |
WO2021174946A1 (zh) * | 2020-10-12 | 2021-09-10 | 平安科技(深圳)有限公司 | 可视化方法、系统、计算机设备和存储介质 |
CN112381155A (zh) * | 2020-11-17 | 2021-02-19 | 上海交通大学 | 基于人工智能的有机物样本处理方法、装置、设备及存储介质 |
WO2023000653A1 (zh) * | 2021-07-19 | 2023-01-26 | 湖南大学 | 一种图卷积神经网络高光谱医药成分分析的实现方法 |
CN113694128A (zh) * | 2021-07-27 | 2021-11-26 | 吉林化工学院 | 一种响应面法优化乌拉草中含有士的宁的生物碱的提取工艺 |
CN114112980A (zh) * | 2022-01-24 | 2022-03-01 | 武汉宏韧生物医药股份有限公司 | 一种基于数据分析的药物组分检测方法与系统 |
Non-Patent Citations (3)
Title |
---|
YANG ZHE等: "An improved method of anomaly recognition of dam safety monitoring data based on M-estimator and standard quartile range" * |
刘云鹏等: "基于多层架构的油中溶解气体数据清洗与异常识别方法研究" * |
毛超一: "基于成分-药效关联的中药菊花质量标准与评价研究" * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118173190A (zh) * | 2024-05-14 | 2024-06-11 | 达州市农业科学研究院(达州市苎麻科学研究所、达州市薯类作物研究所) | 基于大数据的百部药材中有效成份分析系统及方法 |
Also Published As
Publication number | Publication date |
---|---|
CN115825316B (zh) | 2023-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Okada et al. | Metabolomics of medicinal plants: the importance of multivariate analysis of analytical chemistry data | |
CN115825316B (zh) | 基于超临界色谱法的药物有效成分分析方法及装置 | |
CN103149300B (zh) | 黄芪颗粒指纹图谱的测定方法及其特征指纹图谱 | |
Abraham et al. | Chemometric-guided approaches for profiling and authenticating botanical materials | |
Wang et al. | Comprehensive metabolic profile analysis of the root bark of different species of tree peonies (Paeonia Sect. Moutan) | |
Li et al. | Entirely control the quality consistency of Rong’e Yishen oral liquid by both quantified profiling and quantitative analysis of multi-components by single marker method | |
CN102680628B (zh) | 安胃疡指纹图谱的建立方法 | |
CN114034806B (zh) | 基于指纹图谱色谱峰匹配频数统计的中药印迹模板成分簇划归整合方法及产品 | |
CN107727754A (zh) | 一种小金制剂的hplc指纹图谱检测方法 | |
Chen et al. | A support vector machine based pharmacodynamic prediction model for searching active fraction and ingredients of herbal medicine: Naodesheng prescription as an example | |
Yang et al. | UPLC-QTOF-MS with a chemical profiling approach for holistic quality evaluation between a material reference of Wen Dan decoction and its commercial preparations | |
CN105203690B (zh) | 一种荷丹制剂的指纹图谱测定方法 | |
CN112730655B (zh) | 葶苈大枣泻肺颗粒指纹图谱的建立方法 | |
Wang et al. | Quality assessment of Traditional Chinese Medicine using HPLC-PAD combined with Tchebichef image moments | |
CN103472148A (zh) | 一种中药组合物制剂的指纹图谱检测方法 | |
CN102068553B (zh) | 一种治疗气滞血瘀所致乳癖制剂的hplc指纹图谱的构建方法 | |
CN103604878B (zh) | 一种抗衰老片的指纹图谱获取方法、标准指纹图谱及应用 | |
CN108918696B (zh) | 一种健脾益肺方指纹图谱的建立方法及质量控制方法 | |
CN103837621B (zh) | 一种枳实药材指纹图谱、其建立方法及用途 | |
CN113063872B (zh) | 三七姜乙酸乙酯部位的指纹图谱和质量分析方法 | |
Tan et al. | Exploring the mechanisms and molecular targets of Taohong Siwu decoction for the treatment of androgenetic alopecia based on network analysis and molecular docking | |
CN110441414B (zh) | 金水六君煎指纹图谱的建立方法 | |
CN113506592A (zh) | 一种治疗慢性支气管炎中药的机理分析方法 | |
CN113514576A (zh) | 柴胡药材、提取物及单味制剂的指纹图谱的建立方法 | |
Sun et al. | A comparative analysis of Aconiti Lateralis Radix and processed products using UHPLC-Q-TOF-MS combined with multivariate chemometrics strategies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240115 Address after: Building C1/B4, Optics Valley Biotech City, No. 666 Gaoxin Avenue, Donghu High tech Zone, Wuhan City, Hubei Province, 430205 Patentee after: Wuhan Hongren biomedical Co.,Ltd. Patentee after: Shanghai Hongren Biomedical Technology Co.,Ltd. Address before: Room A101, 1st Floor, Building B4, Wuhan National Bioindustry (Jiufeng Innovation) Base, No. 666, Gaoxin Avenue, Wuhan New Technology Development Zone, Hubei Province, 430205 Patentee before: Wuhan Hongren biomedical Co.,Ltd. |